NIDCR'S NEW CLINICAL TRIALS PROGRAM RELEASE DATE: December 9, 2002 NOTICE: NOT-DE-03-002 (Rescinded per Notice NOT-DE-08-002) National Institute of Dental and Craniofacial Research (NIDCR) (http://www.nidcr.nih.gov) PURPOSE OF THIS NOTICE To inform the research community that the NIDCR will focus its clinical trials research program on the conduct of definitive, multicenter Phase III clinical trials. The new clinical trial program to be used by NIDCR can be viewed at http://www.nidcr.nih.gov at Information for Investigators under the heading Clinical Trials. NIDCR's use of these new procedures is effective immediately with the publication of this notice. All new submissions following the publication of this notice must conform to this new process. Applications already submitted to NIH for NIDCR consideration will not be subject to this new process. Resubmission of applications (amended A1 and A2 applications) originally submitted under the discontinued NIDCR Clinical Trial Planning Grant mechanism (PAR-99-157) or the discontinued NIDCR Clinical Trial Pilot Grant mechanism (PAR-99-158) will not be subject to this new process if the principal investigator so desires. The process for submitting a clinical trial proposal, including the review criteria to be used by NIDCR, is described at http://www.nidcr.nih.gov. Each full Phase III clinical trial will consist of the submission of a minimum of two grant applications: one from the Study Chair and one from the Data Coordinating Center. The applications for clinical centers may be submitted as separate grant applications or as subcontracts to the Study Chair or Data Coordinating Center applications. Given the complex nature of multicenter Phase III clinical trials, NIDCR encourages the use of a Data Coordinating Center as an integral part of the clinical trial organization. As part of the Study Chairs' application, NIDCR will require the submission of a detailed Manual of Procedures (MOP). See http://www.nidcr.nih.gov for a model MOP showing the detail required in a well-written MOP. Another example of a detail MOP table of content can be found in Meinert, CL, Clinical Trials Design, Conduct, and Analysis, Oxford University Press, 1986, pp. 417-419. To assist investigators in preparing the final applications for a multicenter Phase III clinical trial, in preparing the MOP, and in finalizing the organizational structure of the clinical trial, the NIDCR has revised the NIDCR Clinical Trial Planning Grant to support this activity (see http://www.nidcr.nih.gov). To provide a mechanism for the collection of preliminary data that is necessary to support the development of definitive Phase III clinical trials, NIDCR has developed the NIDCR Clinical Pilot Data Grant (see http://www.nidcr.nih.gov) NIDCR will use the U01 cooperative agreement mechanism to support Phase III clinical trials. Special Terms and Conditions of award will be associated with these awards since NIDCR staff will have substantive involvement in the development, conduct, and overall management of these clinical trials (see http://www.nidcr.nih.gov). Clinical trial applications will be peer reviewed by an NIDCR special review committee. Criteria to be used by peer review to evaluate each application are described at http://www.nidcr.nih.gov. INQUIRIES Inquiries are strongly encouraged. Opportunities to clarify any issues or questions from potential applicants are welcome. Direct inquiries concerning scope, requirements, and eligibility to: Jane C. Atkinson, D.D.S. Program Director, Clinical Trials Program Center for Clinical Research National Institute of Dental and Craniofacial Research Building 45, Room 4AS25L 45 Center Drive, MSC 6401 Bethesda, MD 20892-6401 Telephone (301) 435-7908 E-mail: jatkinso@mail.nih.gov
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
| ||||||
Department of Health and Human Services (HHS) |
||||||
NIH... Turning Discovery Into Health® |